Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

BACKGROUND. Type 2 diabetes mellitus (T2DM) is associated with increased risk of colon cancer (CC), whereas metformin use seems to be protective. However, the impact of metformin use on the risk of death or disease recurrence after radical surgery for CC remains uncertain. MATERIALS AND METHODS. Thi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncologist
मुख्य लेखकों: Vernieri, Claudio, Galli, Fabio, Ferrari, Laura, Marchetti, Paolo, Lonardi, Sara, Maiello, Evaristo, Iaffaioli, Rosario V., Zampino, Maria G., Zaniboni, Alberto, De Placido, Sabino, Banzi, Maria, Damiani, Azzurra, Ferrari, Daris, Rosati, Gerardo, Labianca, Roberto F., Bidoli, Paolo, Frassineti, Giovanni L., Nicolini, Mario, Pavesi, Lorenzo, Tronconi, Maria C., Buonadonna, Angela, Ferrario, Sabrina, Re, Giovanni Lo, Adamo, Vincenzo, Tamburini, Emiliano, Clerico, Mario, Giordani, Paolo, Leonardi, Francesco, Barni, Sandro, Ciarlo, Andrea, Cavanna, Luigi, Gori, Stefania, Cinieri, Saverio, Faedi, Marina, Aglietta, Massimo, Antista, Maria, Dotti, Katia F., Galli, Francesca, Di Bartolomeo, Maria
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley & Sons, Inc. 2019
विषय:
Gastrointestinal Cancer
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519752/
https://ncbi.nlm.nih.gov/pubmed/30606884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0442
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन